BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9546816)

  • 1. Characterisation of the antibody response to the extracellular region of recombinant thyrotropin receptor.
    Morgenthaler NG; Kim MR; Gardas A; Vlase H; Aust G; Gupta M; McGregor AM; Banga JP
    Autoimmunity; 1997; 26(2):75-84. PubMed ID: 9546816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
    Grasso YZ; Kim MR; Faiman C; Kohn LD; Tahara K; Gupta MK
    Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
    Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
    Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies.
    Akamizu T; Kohn LD; Hiratani H; Saijo M; Tahara K; Nakao K
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2116-21. PubMed ID: 10852437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-bovine TSH antibodies in patients with Graves' disease and primary myxedema.
    Cho BY; Shong YK; Lee HK; Koh CS; Min HK
    Thyroidology; 1989 Apr; 1(1):31-7. PubMed ID: 2484905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
    Kung AW; Lau KS; Kohn LD
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
    Ochi Y; Hamazu M; Kajita Y; Nagata A
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of the semisynthetic library approach for obtaining human monoclonal autoantibodies to the thyrotropin receptor of Graves' disease.
    Van Der Heijden JH; De Bruin TW; Glaudemans KA; De Kruif J; Banga JP; Logtenberg T
    Clin Exp Immunol; 1999 Nov; 118(2):205-12. PubMed ID: 10540180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous assay for three types of thyrotropin receptor antibody activities using FRTL-5 cells in patients with autoimmune thyroid diseases.
    Zhu Y; Portmann L; Dénéréaz N; Lemarchand-Béraud T
    Eur J Endocrinol; 1994 Oct; 131(4):359-68. PubMed ID: 7921224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients.
    Tahara K; Ban T; Minegishi T; Kohn LD
    Biochem Biophys Res Commun; 1991 Aug; 179(1):70-7. PubMed ID: 1883391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
    Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
    Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG; Ho SC; Minich WB
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
    Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunoglobulin G autoantibodies to the thyrotropin receptor from Epstein-Barr virus-transformed B lymphocytes: characterization by immunoprecipitation with recombinant antigen and biological activity.
    Morgenthaler NG; Kim MR; Tremble J; Huang GC; Richter W; Gupta M; Scherbaum WA; McGregor AM; Banga JP
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3155-61. PubMed ID: 8784060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the recombinant human thyrotropin receptor (TSH-R) expressed in mammalian cell lines to assay TSH-R autoantibodies.
    Ludgate M; Perret J; Parmentier M; Gerard C; Libert F; Dumont JE; Vassart G
    Mol Cell Endocrinol; 1990 Oct; 73(1):R13-8. PubMed ID: 1981364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
    Ochi Y; Kajita Y; Hamazu M; Nagata A
    Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.